SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-078546
Filing Date
2024-07-09
Accepted
2024-07-09 16:10:34
Documents
2
Period of Report
2024-07-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2419082-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2419082-1_3seq1.xml 3 1656
2 EXHIBIT 24.1 tm2419082d1_ex24-1.htm EX-24.1 8414
  Complete submission text file 0001104659-24-078546.txt   11541
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140
Business Address
Jorgensen Nathan D. (Reporting) CIK: 0001842523 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37625 | Film No.: 241107559